Biological isolate - United Paragon Associates

Drug Profile

Biological isolate - United Paragon Associates

Alternative Names: Fertilized egg extract - United Paragon Associates; Rellidep

Latest Information Update: 27 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator United Paragon Associates
  • Class Antidepressants; Stem cell therapies
  • Mechanism of Action Glutamate receptor modulators; Neurokinin 2 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Major depressive disorder

Highest Development Phases

  • No development reported Major depressive disorder

Most Recent Events

  • 26 Feb 2016 No development reported - Phase-II/III for Major depressive disorder in Canada (PO)
  • 17 Dec 2013 Biological isolate - United Paragon Associates is available for licensing as of 17 Dec 2013.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top